高薬理活性原薬 (HPAPI)の世界市場（～2026年）

• 英文タイトル：Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12187
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は高薬理活性原薬 (HPAPI)のグローバル市場について調査・分析したレポートです。種類別（合成HPAPI、バイオテクノロジーHPAPI）市場規模、用途別（中枢神経系障害、腫瘍学、ホルモン障害、緑内障、感染症、代謝障害、心血管、炎症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別高薬理活性原薬 (HPAPI)の競争状況、市場シェア
・世界の高薬理活性原薬 (HPAPI)市場：種類別市場規模 2015年-2020年（合成HPAPI、バイオテクノロジーHPAPI）
・世界の高薬理活性原薬 (HPAPI)市場：種類別市場規模予測 2021年-2026年（合成HPAPI、バイオテクノロジーHPAPI）
・世界の高薬理活性原薬 (HPAPI)市場：用途別市場規模 2015年-2020年（中枢神経系障害、腫瘍学、ホルモン障害、緑内障、感染症、代謝障害、心血管、炎症）
・世界の高薬理活性原薬 (HPAPI)市場：用途別市場規模予測 2021年-2026年（中枢神経系障害、腫瘍学、ホルモン障害、緑内障、感染症、代謝障害、心血管、炎症）
・北米の高薬理活性原薬 (HPAPI)市場分析：米国、カナダ
・ヨーロッパの高薬理活性原薬 (HPAPI)市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの高薬理活性原薬 (HPAPI)市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の高薬理活性原薬 (HPAPI)市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの高薬理活性原薬 (HPAPI)市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Alkermes、Cambrex、Dishman、Dr. Reddy’S、Lonza、Novasep、Thermo Fisher Scientific、Pfizer、Merck Kgaa、Tapi Teva
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3.

Market Analysis and Insights: Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market
The global High Potency Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global High Potency Active Pharmaceutical Ingredients (HPAPI) Scope and Market Size
High Potency Active Pharmaceutical Ingredients (HPAPI) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Potency Active Pharmaceutical Ingredients (HPAPI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Alkermes
Cambrex
Dishman
Dr. Reddy’S
Lonza
Novasep
Thermo Fisher Scientific
Pfizer
Merck Kgaa
Tapi Teva

Market segment by Type, the product can be split into
Synthetic HPAPIs
Biotech HPAPIs
Market segment by Application, split into
Central Nervous System Disorders
Oncology
Hormonal Disorders
Glaucoma
Infectious Diseases
Metabolic Disorders
Cardiovascular
Inflammation

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue
1.4 Market by Type
1.4.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Synthetic HPAPIs
1.4.3 Biotech HPAPIs
1.5 Market by Application
1.5.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application: 2020 VS 2026
1.5.2 Central Nervous System Disorders
1.5.3 Oncology
1.5.4 Hormonal Disorders
1.5.5 Glaucoma
1.5.6 Infectious Diseases
1.5.7 Metabolic Disorders
1.5.8 Cardiovascular
1.5.9 Inflammation
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Perspective (2015-2026)
2.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Growth Trends by Regions
2.2.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Historic Market Share by Regions (2015-2020)
2.2.3 High Potency Active Pharmaceutical Ingredients (HPAPI) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Growth Strategy
2.3.6 Primary Interviews with Key High Potency Active Pharmaceutical Ingredients (HPAPI) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top High Potency Active Pharmaceutical Ingredients (HPAPI) Players by Market Size
3.1.1 Global Top High Potency Active Pharmaceutical Ingredients (HPAPI) Players by Revenue (2015-2020)
3.1.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Players (2015-2020)
3.1.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Concentration Ratio
3.2.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue in 2019
3.3 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players Head office and Area Served
3.4 Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Product Solution and Service
3.5 Date of Enter into High Potency Active Pharmaceutical Ingredients (HPAPI) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Historic Market Size by Type (2015-2020)
4.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)
5.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
6.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in North America (2019-2020)
6.3 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
6.4 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

7 Europe
7.1 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
7.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in Europe (2019-2020)
7.3 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
7.4 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

8 China
8.1 China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
8.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in China (2019-2020)
8.3 China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
8.4 China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

9 Japan
9.1 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
9.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in Japan (2019-2020)
9.3 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
9.4 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
10.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
10.4 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

11 India
11.1 India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
11.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in India (2019-2020)
11.3 India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
11.4 India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (2015-2020)
12.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Players in Central & South America (2019-2020)
12.3 Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020)
12.4 Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Alkermes
13.1.1 Alkermes Company Details
13.1.2 Alkermes Business Overview
13.1.3 Alkermes High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.1.4 Alkermes Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020))
13.1.5 Alkermes Recent Development
13.2 Cambrex
13.2.1 Cambrex Company Details
13.2.2 Cambrex Business Overview
13.2.3 Cambrex High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.2.4 Cambrex Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.2.5 Cambrex Recent Development
13.3 Dishman
13.3.1 Dishman Company Details
13.3.2 Dishman Business Overview
13.3.3 Dishman High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.3.4 Dishman Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.3.5 Dishman Recent Development
13.4 Dr. Reddy’S
13.4.1 Dr. Reddy’S Company Details
13.4.2 Dr. Reddy’S Business Overview
13.4.3 Dr. Reddy’S High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.4.4 Dr. Reddy’S Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.4.5 Dr. Reddy’S Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.5.4 Lonza Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 Novasep
13.6.1 Novasep Company Details
13.6.2 Novasep Business Overview
13.6.3 Novasep High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.6.4 Novasep Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.6.5 Novasep Recent Development
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Details
13.7.2 Thermo Fisher Scientific Business Overview
13.7.3 Thermo Fisher Scientific High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.7.4 Thermo Fisher Scientific Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.7.5 Thermo Fisher Scientific Recent Development
13.8 Pfizer
13.8.1 Pfizer Company Details
13.8.2 Pfizer Business Overview
13.8.3 Pfizer High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.8.4 Pfizer Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.8.5 Pfizer Recent Development
13.9 Merck Kgaa
13.9.1 Merck Kgaa Company Details
13.9.2 Merck Kgaa Business Overview
13.9.3 Merck Kgaa High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.9.4 Merck Kgaa Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.9.5 Merck Kgaa Recent Development
13.10 Tapi Teva
13.10.1 Tapi Teva Company Details
13.10.2 Tapi Teva Business Overview
13.10.3 Tapi Teva High Potency Active Pharmaceutical Ingredients (HPAPI) Introduction
13.10.4 Tapi Teva Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020)
13.10.5 Tapi Teva Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. High Potency Active Pharmaceutical Ingredients (HPAPI) Key Market Segments
Table 2. Key Players Covered: Ranking by High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue
Table 3. Ranking of Global Top High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthetic HPAPIs
Table 6. Key Players of Biotech HPAPIs
Table 7. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Regions (2015-2020)
Table 11. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. High Potency Active Pharmaceutical Ingredients (HPAPI) Market Growth Strategy
Table 17. Main Points Interviewed from Key High Potency Active Pharmaceutical Ingredients (HPAPI) Players
Table 18. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue by Players (2015-2020) (Million US$)
Table 19. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Players (2015-2020)
Table 20. Global Top High Potency Active Pharmaceutical Ingredients (HPAPI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) as of 2019)
Table 21. Global High Potency Active Pharmaceutical Ingredients (HPAPI) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Product Solution and Service
Table 24. Date of Enter into High Potency Active Pharmaceutical Ingredients (HPAPI) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 27. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Share by Type (2015-2020)
Table 28. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Type (2021-2026)
Table 29. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Share by Application (2015-2020)
Table 30. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 31. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size Share by Application (2021-2026)
Table 32. North America Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 34. North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 35. North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 36. North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 37. North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 38. Europe Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 40. Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 42. Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 44. China Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 45. China Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 46. China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 47. China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 48. China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 49. China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 50. Japan Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 52. Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 54. Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 58. Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 60. Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 62. India Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 63. India Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 64. India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 65. India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 66. India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 67. India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share (2019-2020)
Table 70. Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type (2015-2020)
Table 72. Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application (2015-2020)
Table 74. Alkermes Company Details
Table 75. Alkermes Business Overview
Table 76. Alkermes Product
Table 77. Alkermes Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 78. Alkermes Recent Development
Table 79. Cambrex Company Details
Table 80. Cambrex Business Overview
Table 81. Cambrex Product
Table 82. Cambrex Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 83. Cambrex Recent Development
Table 84. Dishman Company Details
Table 85. Dishman Business Overview
Table 86. Dishman Product
Table 87. Dishman Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 88. Dishman Recent Development
Table 89. Dr. Reddy’S Company Details
Table 90. Dr. Reddy’S Business Overview
Table 91. Dr. Reddy’S Product
Table 92. Dr. Reddy’S Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 93. Dr. Reddy’S Recent Development
Table 94. Lonza Company Details
Table 95. Lonza Business Overview
Table 96. Lonza Product
Table 97. Lonza Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 98. Lonza Recent Development
Table 99. Novasep Company Details
Table 100. Novasep Business Overview
Table 101. Novasep Product
Table 102. Novasep Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 103. Novasep Recent Development
Table 104. Thermo Fisher Scientific Company Details
Table 105. Thermo Fisher Scientific Business Overview
Table 106. Thermo Fisher Scientific Product
Table 107. Thermo Fisher Scientific Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 108. Thermo Fisher Scientific Recent Development
Table 109. Pfizer Business Overview
Table 110. Pfizer Product
Table 111. Pfizer Company Details
Table 112. Pfizer Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 113. Pfizer Recent Development
Table 114. Merck Kgaa Company Details
Table 115. Merck Kgaa Business Overview
Table 116. Merck Kgaa Product
Table 117. Merck Kgaa Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 118. Merck Kgaa Recent Development
Table 119. Tapi Teva Company Details
Table 120. Tapi Teva Business Overview
Table 121. Tapi Teva Product
Table 122. Tapi Teva Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) Business (2015-2020) (Million US$)
Table 123. Tapi Teva Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Type: 2020 VS 2026
Figure 2. Synthetic HPAPIs Features
Figure 3. Biotech HPAPIs Features
Figure 4. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Application: 2020 VS 2026
Figure 5. Central Nervous System Disorders Case Studies
Figure 6. Oncology Case Studies
Figure 7. Hormonal Disorders Case Studies
Figure 8. Glaucoma Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Metabolic Disorders Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Inflammation Case Studies
Figure 13. High Potency Active Pharmaceutical Ingredients (HPAPI) Report Years Considered
Figure 14. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Regions: 2020 VS 2026
Figure 16. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share by Players in 2019
Figure 19. Global Top High Potency Active Pharmaceutical Ingredients (HPAPI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Potency Active Pharmaceutical Ingredients (HPAPI) as of 2019
Figure 20. The Top 10 and 5 Players Market Share by High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue in 2019
Figure 21. North America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed

以下、関連資料のご紹介

HPAPI（高力価有効成分）の世界市場（～2026年）

Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Insights and Forecast to 2026
MRC2-11QY01411 2020年11月20日 111Pages
当調査資料はHPAPI（高力価有効成分）のグローバル市場について調査・分析したレポートです。種類別（革新的HPAPI、汎用HPAPI）市場規模、用途別（キャプティブHPAPI、マーチャントHPAPI）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

高性能医薬品有効成分（HPAPI）の世界市場（～2026年）

Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Insights and Forecast to 2026
MRC2-11QY01193 2020年11月20日 112Pages
当調査資料は高性能医薬品有効成分（HPAPI）のグローバル市場について調査・分析したレポートです。種類別（合成成分、生物成分、その他）市場規模、用途別（腫瘍学、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

高力価医薬品有効成分（API）の世界市場（～2026年）

Global High Potency Active Pharmaceutical Ingredients (APIs) Market Insights and Forecast to 2026
MRC2-11QY01212 2020年11月20日 154Pages
当調査資料は高力価医薬品有効成分（API）のグローバル市場について調査・分析したレポートです。種類別（合成、バイオテクノロジー）市場規模、用途別（腫瘍学、ホルモン、緑内障、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

ジェネリック医薬品有効成分の世界市場（～2026年）

Global Generic Active Pharmaceutical Ingredients Market Insights and Forecast to 2026
MRC2-11QY06747 2020年11月20日 118Pages
当調査資料はジェネリック医薬品有効成分のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）市場規模、用途別（腫瘍学、糖尿病、心血管疾患、CNS・神経障害、内分泌学、その他）市場規模、地域別（北米、米国...

インスリン有効成分の世界市場（～2026年）

Global Insulin Active Pharmaceutical Ingredient Market Insights and Forecast to 2026
MRC2-11QY01752 2020年11月20日 110Pages
当調査資料はインスリン有効成分のグローバル市場について調査・分析したレポートです。種類別（化学合成、動物抽出物）市場規模、用途別（動物インスリン、通常ヒトインスリン、インスリンアナログ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

パーソナルケア用有効成分の世界市場（～2026年）

Global Active Ingredients in Personal Care Market Insights and Forecast to 2026
MRC2-11QY02078 2020年11月20日 149Pages
当調査資料はパーソナルケア用有効成分のグローバル市場について調査・分析したレポートです。種類別（天然、合成）市場規模、用途別（スキンケア、ヘアケア、オーラルケア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

医薬品有効成分の世界市場（～2026年）

Global Active Pharma Ingredient Market Insights and Forecast to 2026
MRC2-11QY02082 2020年11月20日 183Pages
当調査資料は医薬品有効成分のグローバル市場について調査・分析したレポートです。種類別（革新的医薬品有効成分、ジェネリック医薬品有効成分）市場規模、用途別（腫瘍学、心血管疾患、糖尿病、中枢神経系・神経障害、内分泌学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...

製薬植物抽出物の世界市場（～2026年）

Global Pharmaceutical Plant Extracts Market Insights and Forecast to 2026
MRC2-11QY13696 2020年11月30日 183Pages
当調査資料は製薬植物抽出物のグローバル市場について調査・分析したレポートです。種類別（非標準化抽出物、標準化抽出物）市場規模、用途別（医学、食品、化粧品、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

バイオアクティブプロテインの世界市場（～2026年）

Global Bio Active Protein Market Insights and Forecast to 2026
MRC2-11QY03141 2020年11月20日 118Pages
当調査資料はバイオアクティブプロテインのグローバル市場について調査・分析したレポートです。種類別（植物源、マメ科植物源、動物源、乳製品、その他）市場規模、用途別（がん、心臓病、化粧品、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

アクティブニュートリションの世界市場（～2026年）

Global Active Nutrition Market Insights and Forecast to 2026
MRC2-11QY02080 2020年11月20日 119Pages
当調査資料はアクティブニュートリションのグローバル市場について調査・分析したレポートです。種類別（消費者健康、清涼飲料、パッケージ食品）市場規模、用途別（スポーツ栄養、タンパク質サプリメント）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...

HPAPI（高力価有効成分）の世界市場（～2026年） Market Analysis and Insights: Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market The global HPAPI (High Potency Active Pharmaceutical Ingredients) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global HPAPI…
高性能医薬品有効成分（HPAPI）の世界市場（～2026年） Market Analysis and Insights: Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market The global High Performance Active Pharmaceutical Ingredients (HPAPI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Glob…
高力価医薬品有効成分（API）の世界市場（～2026年） High Potency Active Pharmaceutical Ingredients (APIs) have higher active level targeting sever diseases such as tumour cells, infected cells, damaged organs than regular medicine elements. Highly potent APIs are capable of targeting diseased cell selectively and more precisely than other compounds. …
ジェネリック医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Generic Active Pharmaceutical I…
パーソナルケア用有効成分の世界市場（～2026年） The active ingredients in these products enter the wastewater collection system following hand-washing, bathing, and laundry-washing. North America was followed by Europe and Asia-Pacific as second and third largest market for the active ingredients in personal care market. Market Analysis and Insig…